Histogenics (HSGX) Misses Q3 EPS by 21c

Histogenics (NASDAQ: HSGX) reported Q3 EPS of ($0.70), $0.21 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Histogenics (HSGX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance